ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
06 November 2023 - 2:31PM
ReShape Lifesciences Inc. (Nasdaq:
RSLS), the premier physician-led weight loss and metabolic
health-solutions company, today announced that it will report its
financial results for the third quarter ended September 30, 2023,
including a corporate update on Wednesday, November 8, 2023, after
market.
Management will host a conference call on
November 8 at 5:00 pm ET. A live webcast will be available on the
“Events and Presentations” section of ReShape’s website at:
https://ir.reshapelifesciences.com/events-and-presentations.
To access the call by phone, please register
with the following Registration Link, and dial-in details will be
provided. Participants using this feature are requested to dial
into the conference call fifteen minutes ahead of time to avoid
delays. An archived replay will also be available on the “Events
and Presentations” section of ReShape’s website at:
https://ir.reshapelifesciences.com/events-and-presentations.
About ReShape Lifesciences®ReShape
Lifesciences® is America’s premier weight loss and metabolic
health-solutions company, offering an integrated portfolio of
proven products and services that manage and treat obesity and
metabolic disease. The FDA-approved Lap-Band® System provides
minimally invasive, long-term treatment of obesity and is an
alternative to more invasive surgical stapling procedures such as
the gastric bypass or sleeve gastrectomy. The investigational
Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system utilizes a
proprietary vagus nerve block and stimulation technology platform
for the treatment of type 2 diabetes and metabolic disorders. The
Obalon® balloon technology is a non-surgical, swallowable,
gas-filled intra-gastric balloon that is designed to provide
long-lasting weight loss. For more information, please visit
www.reshapelifesciences.com.
CONTACTS:Company
Contact:
Thomas StankovichChief Financial
Officer949-276-6042ir@ReShapeLifesci.com
Investor Relations Contact:Rx
Communications GroupMichael
Miller(917)-633-6086mmiller@rxir.com
ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
Von Jul 2023 bis Jul 2024